Excelimmune excelimmune.com


Public lists: Pharma Startups (4732)

Excelimmune is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. This next generation technology is applicable to the treatment of diseases and infections caused by common bacteria, disease-causing proteins and viral pathogens.

Excelimmune is a biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans. This next generation technology is applicable to the treatment of diseases and i...Show all

Company (Alive / Active)

Phone:

Fax:

519 Somerville Avenue
PMB 214
Woburn, 02143
Massachusetts, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Excelimmune $28.2M Dec 12, 2011
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Excelimmune Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods for producing recombinant proteins Sep 26, 2013 Sep 20, 2016 Patent
Methods for producing recombinant proteins Jun 13, 2012 Dec 31, 2013 Patent
Staphylococcus aureus specific human recombinant polyclonal antibodies and uses thereof Jul 26, 2013 Application